These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 8839400)

  • 1. Transfusion-associated graft-versus-host disease and its prevention.
    Williamson LM; Warwick RM
    Blood Rev; 1995 Dec; 9(4):251-61. PubMed ID: 8839400
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [HLA typing in a neonate with posttransfusional graft vs host disease (PT-GVHD)].
    Lista GL; Porcelli F; Mercuriali F; Farè M; Taccone F
    Pediatr Med Chir; 1994; 16(3):285-7. PubMed ID: 7971455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transfusion-associated graft-versus-host disease guideline on gamma irradiation of blood components].
    Landi EP; de Oliveira JS
    Rev Assoc Med Bras (1992); 1999; 45(3):261-72. PubMed ID: 10513059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
    Shivdasani RA; Anderson KC
    Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-associated graft-versus-host disease.
    Rühl H; Bein G; Sachs UJ
    Transfus Med Rev; 2009 Jan; 23(1):62-71. PubMed ID: 19056035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatal graft-versus-host disease associated with transfusions of HLA-matched, HLA-homozygous platelets from unrelated donors.
    Benson K; Marks AR; Marshall MJ; Goldstein JD
    Transfusion; 1994 May; 34(5):432-7. PubMed ID: 8191569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HLA homozygosity and the risk of related-donor transfusion-associated graft-versus-host disease.
    McMilin KD; Johnson RL
    Transfus Med Rev; 1993 Jan; 7(1):37-41. PubMed ID: 8431657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Transfusion-associated graft-vs-host disease].
    Lillevang ST; Kristensen T
    Ugeskr Laeger; 1992 Oct; 154(43):2964-8. PubMed ID: 1462384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The critical role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease in immunocompetent patients.
    Otsuka S; Kunieda K; Kitamura F; Misawa K; Sasaoka I; Hirose M; Kasuya S; Saji S; Noma A
    Transfusion; 1991; 31(3):260-4. PubMed ID: 2003327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Transfusion-associated graft-versus-host disease. Increased risk when using HLA matched donors].
    Hovdenes J; Solheim BG
    Tidsskr Nor Laegeforen; 1995 May; 115(12):1499-501. PubMed ID: 7770854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transfusion-associated graft-versus-host disease.
    Orlin JB; Ellis MH
    Curr Opin Hematol; 1997 Nov; 4(6):442-8. PubMed ID: 9359003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transfusion associated graft versus host disease in an immunocompetent patient.
    O'Connor NT; Mackintosh P
    J Clin Pathol; 1992 Jul; 45(7):621-2. PubMed ID: 1517464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.
    Petz LD; Calhoun L; Yam P; Cecka M; Schiller G; Faitlowicz AR; Herron R; Sayah D; Wallace RB; Belldegrun A
    Transfusion; 1993 Sep; 33(9):742-50. PubMed ID: 8105567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fatal transfusion-associated graft-versus-host disease in an immunocompetent recipient of a volunteer unit of red cells.
    Triulzi D; Duquesnoy R; Nichols L; Clark K; Jukic D; Zeevi A; Meisner D
    Transfusion; 2006 Jun; 46(6):885-8. PubMed ID: 16734803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion-associated graft-versus-host disease and the irradiation of blood components.
    Davey RJ
    Immunol Invest; 1995; 24(1-2):431-4. PubMed ID: 7713602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA-based HLA typing of nonhematopoietic tissue used to select the marrow transplant donor for successful treatment of transfusion-associated graft-versus-host disease.
    Friedman DF; Kwittken P; Cizman B; Argyris E; Kearns J; Yang SY; Zmijewski C; Bunin N; Douglas SD; Monos D
    Clin Diagn Lab Immunol; 1994 Sep; 1(5):590-6. PubMed ID: 8556506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Transfusion-associated graft-versus-host disease].
    Bojanić I; Cepulić BG
    Lijec Vjesn; 2004; 126(1-2):39-47. PubMed ID: 15526751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfusion-associated graft-versus-host disease: do transfusions from second-degree relatives pose a greater risk than those from first-degree relatives?
    Kanter MH
    Transfusion; 1992 May; 32(4):323-7. PubMed ID: 1585436
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfusion-associated graft-versus-host disease in a presumably immunocompetent patient after transfusion of stored packed red cells.
    Suzuki K; Akiyama H; Takamoto S; Maruyama Y; Sakamaki H; Akagi K; Maeda Y; Takenaka M; Onozawa Y
    Transfusion; 1992 May; 32(4):358-60. PubMed ID: 1585443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of transfusion-associated graft-versus-host disease.
    Yasukawa M; Shinozaki F; Hato T; Takada K; Ishii Y; Tamai T; Takamatsu H; Shiobara S; Yoshizaki K; Fujita S
    Br J Haematol; 1994 Apr; 86(4):831-6. PubMed ID: 7918080
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.